Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies

Nicholas G. Zaorsky, Eric J. Lehrer, Gargi Kothari, Alexander V. Louie, Shankar Siva

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

Stereotactic radiotherapy is safe and efficacious in the management of extracranial and intracranial renal cell oligometastases, with local control at 90% and any significant toxicity at 1%.

Original languageEnglish (US)
JournalEuropean Urology Oncology
DOIs
StatePublished - Jan 1 2019

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Urology

Fingerprint Dive into the research topics of 'Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies'. Together they form a unique fingerprint.

  • Cite this